Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today
Links shared publicly online about this topic.
- 369total visits
Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today
HONOLULU -- Relapses and/or disease progression are common among multiple sclerosis patients taking natalizumab (Tysabri) who stop the drug, casting doubt on drug holidays as a strategy for minimizi
View full resource at medpagetoday.com
Tags: Multiple Sclerosis, Disease and Condition, Tysabri, News, disease, Holiday, Medical
Most Recently Shared on April 12, 2011 at 11:22 pm By:
AAN: Studies Nix Natalizumab Holidays (CME/CE) http://bit.ly/eBRhwp
Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Relapses and/or disease progression are common among multiple sclerosis patients taking natalizumab (Tysabri) who stop the drug, casting doubt on drug holidays as a strategy for minimizi” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:49 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: AAN: Studies Nix Natalizumab Holidays - in Meeting Coverage, AAN from MedPage Today - http://t.co/C6cWGuV from @medpagetoday
Advertisement
